Healthcare Holding B.V. Gilde Sells 7,338 Shares of Shoulder Innovations (NYSE:SI) Stock

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock in a transaction that occurred on Wednesday, August 5th. The stock was sold at an average price of $22.64, for a total value of $166,132.32. Following the completion of the sale, the insider directly owned 2,214,302 shares in the company, valued at $50,131,797.28. This represents a 0.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.60, for a total value of $47,347.00.
• On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.77, for a total value of $2,272,719.24.
• On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.71, for a total transaction of $244,155.21.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.73, for a total transaction of $455,372.82.
• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The shares were sold at an average price of $23.36, for a total transaction of $659,803.20.

Shoulder Innovations Price Performance

Shares of NYSE:SI traded down $1.89 during midday trading on Friday, hitting $20.54. The company’s stock had a trading volume of 286,871 shares, compared to its average volume of 93,468. The company has a market cap of $426.06 million and a P/E ratio of -0.12. Shoulder Innovations, Inc. has a 12-month low of $10.92 and a 12-month high of $24.59. The business’s 50 day simple moving average is $19.79 and its 200 day simple moving average is $16.04. The company has a debt-to-equity ratio of 0.11, a quick ratio of 10.04 and a current ratio of 11.81.

Shoulder Innovations (NYSE:SI) last announced its quarterly earnings data on Wednesday, May 13th. The company reported ($0.41) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.44) by $0.03. The company had revenue of $16.71 million during the quarter. Shoulder Innovations had a negative net margin of 81.78% and a negative return on equity of 35.11%. On average, analysts forecast that Shoulder Innovations, Inc. will post -1.67 EPS for the current year.

Institutional Trading of Shoulder Innovations

Several hedge funds have recently made changes to their positions in the company. Rhumbline Advisers purchased a new stake in shares of Shoulder Innovations during the 3rd quarter valued at approximately $54,000. Vanguard Group Inc. purchased a new position in Shoulder Innovations in the third quarter worth approximately $1,836,000. Deerfield Management Company L.P. acquired a new stake in Shoulder Innovations during the third quarter worth $6,056,000. Bank of America Corp DE acquired a new stake in Shoulder Innovations during the third quarter worth $322,000. Finally, Citadel Advisors LLC purchased a new stake in Shoulder Innovations in the third quarter valued at $628,000.

Analyst Ratings Changes

Several research firms recently commented on SI. Weiss Ratings raised Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a report on Monday. UBS Group assumed coverage on Shoulder Innovations in a research note on Tuesday, July 28th. They set a “buy” rating and a $27.00 price objective on the stock. BTIG Research raised their target price on Shoulder Innovations from $24.00 to $26.00 and gave the stock a “buy” rating in a research note on Friday. Finally, Piper Sandler reiterated an “overweight” rating and set a $25.00 price target (up from $19.00) on shares of Shoulder Innovations in a report on Friday. Six investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Shoulder Innovations has an average rating of “Moderate Buy” and a consensus price target of $23.33.

Shoulder Innovations News Summary

Here are the key news stories impacting Shoulder Innovations this week:

• Positive Sentiment: Analysts raised their targets: Piper Sandler reaffirmed its “overweight” rating and lifted its price target from $19 to $25, while BTIG Research raised its target from $24 to $26 and initiated a “buy” rating. These targets imply meaningful upside and may support investor sentiment. Benzinga analyst rating updates
• Positive Sentiment: Revenue growth remained strong: Second-quarter revenue increased approximately 56% year over year to $17.2 million, slightly exceeding estimates. Gross profit rose about 60%, indicating continued demand and improving product economics. Shoulder Innovations Q2 2026 earnings summary
• Positive Sentiment: Full-year guidance was raised: SI forecast fiscal-year revenue of $67 million to $69 million, broadly in line with the roughly $67.1 million consensus estimate. Management also highlighted 60% first-half revenue growth. Shoulder Innovations raises full-year outlook
• Neutral Sentiment: Liquidity appears adequate but is declining: The company ended the quarter with $24.5 million in cash and used $7.4 million in operating activities and $2.2 million in capital expenditures. Investors will likely monitor whether revenue growth can lead to improved cash generation.
• Negative Sentiment: Profitability remains a concern: SI reported an operating loss of about $10 million, a net loss of approximately $10.2 million, and diluted EPS near negative $0.49, missing some estimates. The company remains deeply unprofitable, increasing valuation sensitivity. Shoulder Innovations quarterly results
• Negative Sentiment: Major-holder selling may weigh on sentiment: Gilde Healthcare sold more than 110,000 shares in early August for roughly $2.5 million. Although it retains a substantial stake, the sales can raise concerns about near-term supply and insider conviction. Gilde Healthcare insider sale

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.